Search

for
Search:

Sort by

Research

510-540 / 1000+ results

research Characterizing Lipid Changes and Use of Lipid-Lowering Medications in Patients With Alopecia Areata Treated With Baricitinib: Integrated Results From the BRAVE-AA1 and -AA2 Clinical Trials

November 2024 in “SKIN The Journal of Cutaneous Medicine”

Baricitinib slightly increased cholesterol levels in alopecia areata patients, but these changes were manageable.

research The first clinical trial of topical application of procyanidin B‐2 to investigate its potential as a hair growing agent

26 citations , June 2001 in “PTR. Phytotherapy research/Phytotherapy research”

Procyanidin B-2 lotion might help men grow thicker hair without side effects.

Antroquinonol Exerts Immunosuppressive Effect on CD8+ T Cell Proliferation and Activation to Resist Depigmentation Induced by H2O2

research Antroquinonol Exerts Immunosuppressive Effect on CD8⁺ T Cell Proliferation and Activation to Resist Depigmentation Induced by H₂O₂

11 citations , January 2017 in “Oxidative medicine and cellular longevity”

Antroquinonol may help prevent skin depigmentation by suppressing certain immune cells.

research Janus Kinase Inhibitors in the Treatment of Alopecia Areata

2 citations , January 2023 in “Prague Medical Report”

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

research Therapeutic Efficacy of Combination Therapy Using Oral Cyclosporine with a Dietary Supplement (Pantogar®) in Twenty-Nail Dystrophy

7 citations , January 2017 in “Annals of Dermatology”

Oral cyclosporine combined with Pantogar® effectively treats twenty-nail dystrophy.

Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A Promising Therapy for the Treatment of Alopecia Areata: A Case Report of Six Patients

research Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients

24 citations , January 2018 in “International Journal of Trichology”

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

The Non-Neuronal and Nonmuscular Effects of Botulinum Toxin: An Opportunity for a Deadly Molecule to Treat Disease in the Skin and Beyond

research The non-neuronal and nonmuscular effects of botulinum toxin: an opportunity for a deadly molecule to treat disease in the skin and beyond

44 citations , October 2017 in “British Journal of Dermatology”

Botulinum toxin has potential for treating various skin conditions and improving wound healing.

research Supplementary Material for: Use of Botulinum Toxin for Androgenic Alopecia: A Systematic Review

January 2021 in “Figshare”

Botulinum toxin may be helpful for treating male pattern baldness.

research Adherence to topical hydrocortisone 17-butyrate 0.1% in different vehicles in adults with atopic dermatitis

16 citations , December 2008 in “Journal of The American Academy of Dermatology”

Adults with atopic dermatitis showed similar adherence to different forms of hydrocortisone cream, but actual use varied despite self-reports of near-perfect usage.

research Electrospun radially oriented berberine-PHBV nanofiber dressing patches for accelerating diabetic wound healing

49 citations , January 2024 in “Regenerative Biomaterials”

The new nanofiber patch speeds up diabetic wound healing and improves healing quality.

Comparison of the Efficacy of Topical Methotrexate 1% Gel Versus Topical Betamethasone Dipropionate 0.05% Lotion in the Treatment of Localized Scalp Alopecia Areata in a Tertiary Care Institute of Central India: A Randomized Control Trial

research Comparison of the Efficacy of Topical Methotrexate 1% gel Versus Topical Betamethasone Dipropionate 0.05% Lotion in the Treatment of Localized Scalp Alopecia Areata in a Tertiary Care Institute of Central India: A Randomized Control Trial

August 2025 in “Indian Dermatology Online Journal”

Both treatments work equally well for hair regrowth, but the lotion has fewer side effects.

research Baricitinib Induced Hypoglycemic Seizures in a Patient with Hair Loss and Type I Diabetes Mellitus: A Case Report

May 2026 in “SKIN The Journal of Cutaneous Medicine”

Baricitinib may cause low blood sugar in some patients, so careful monitoring is needed.

research Enzalutamide/finasteride/goserelin/zoledronic-acid

July 2024 in “Reactions Weekly”

research Tofacitinib for the treatment of severe alopecia areata and variants: A retrospective cohort study of 90 patients

June 2017 in “Journal of the American Academy of Dermatology”

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

research Topical niacinamide 4% and desonide 0.05% for treatment of axillary hyperpigmentation: a randomized, double-blind, placebo-controlled study

40 citations , January 2013 in “Clinical Cosmetic and Investigational Dermatology”

Desonide is more effective than niacinamide for reducing underarm darkening.

research A Randomized, Double-Blind, Placebo-Controlled Pilot Study to Evaluate the Efficacy and Safety of Latanoprost for Eyelash Growth in Aesthetic Medicine

2 citations , October 2023 in “Cosmetics”

Latanoprost effectively and safely promotes eyelash growth.

research Strong efficacy of ritlecitinib 50 mg and baricitinib 4 mg in alopecia areata, but further research needed to establish superiority

1 citations , May 2025 in “Journal of the European Academy of Dermatology and Venereology”

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

research Toxina botulínica, rompiendo el paradigma en el abordaje por dermatología, cirugía plástica y neurología

January 2023 in “Dialnet (Universidad de la Rioja)”

Botulinum toxin is used to treat many medical conditions beyond cosmetic purposes.

Steroid-Free Monotherapy with Tofacitinib in Severe Therapy-Resistant Alopecia: A Retrospective Analysis

research A Real-World Study of Steroid-Free Monotherapy with Tofacitinib in Severe and Therapy-Recalcitrant Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Cases: A Retrospective Analysis

November 2023 in “Indian Dermatology Online Journal”

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Topical Latanoprost Acid for Female Androgenetic Alopecia: A Pilot Proof-Of-Concept Trial With Mechanistic Evidence of FP-Receptor Activation

research Topical latanoprost acid for female androgenetic alopecia: a pilot proof-of-concept trial with mechanistic evidence of FP-receptor activation

March 2026

Topical latanoprost acid at 0.05% concentration improved hair growth in women with androgenetic alopecia.

research Experience with oral tofacitinib in 8 adolescent patients with alopecia universalis

49 citations , March 2017 in “Journal of the American Academy of Dermatology”

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

research Management of Hypotrichosis of the Eyelashes

6 citations , April 2015 in “Plastic surgical nursing”

Bimatoprost ophthalmic solution 0.03% is a safe and effective way to increase eyelash growth.

Post-Burns Hair Restoration of Eyebrow, Eyelash, Moustache, Beard, and Scalp Areas

research 43665 Participant Satisfaction Survey Outcomes in a Comparative At-Home Photobiomodulation Device Study for Hair Loss

September 2023 in “Journal of The American Academy of Dermatology”

People were generally happy with the home light therapy devices for hair loss.

← Previous page Next page →